A novel score system of blood tests for differentiating Kawasaki disease from febrile children
- PMID: 33481812
- PMCID: PMC7822339
- DOI: 10.1371/journal.pone.0244721
A novel score system of blood tests for differentiating Kawasaki disease from febrile children
Abstract
Background: Kawasaki disease is the most common cause of acquired heart disease among febrile children under the age of 5 years old. It is also a clinically diagnosed disease. In this study, we developed and assessed a novel score system using objective parameters to differentiate Kawasaki disease from febrile children.
Methods: We analyzed 6,310 febrile children and 485 Kawasaki disease subjects in this study. We collected biological parameters of a routine blood test, including complete blood count with differential, C-reactive protein, aspartate aminotransferase, and alanine aminotransferase. Receiver operating characteristic curve, logistic regression, and Youden's index were all used to develop the prediction model. Two other independent cohorts from different hospitals were used for verification.
Results: We obtained eight independent predictors (platelets, eosinophil, alanine aminotransferase, C-reactive protein, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and monocyte) and found the top three scores to be eosinophil >1.5% (score: 7), alanine aminotransferase >30 U/L (score: 6), and C-reactive protein>25 mg/L (score: 6). A score of 14 represents the best sensitivity value plus specificity prediction rate for Kawasaki disease. The sensitivity, specificity, and accuracy for our cohort were 0.824, 0.839, and 0.838, respectively. The verification test of two independent cohorts of Kawasaki disease patients (N = 103 and 170) from two different institutes had a sensitivity of 0.780 (213/273).
Conclusion: Our findings demonstrate a novel score system with good discriminatory ability for differentiating between children with Kawasaki disease and other febrile children, as well as highlight the importance of eosinophil in Kawasaki disease. Using this novel score system can help first-line physicians diagnose and then treat Kawasaki disease early.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses.BMC Med. 2011 Dec 6;9:130. doi: 10.1186/1741-7015-9-130. BMC Med. 2011. PMID: 22145762 Free PMC article.
-
The association of serum CHI3L1 levels with the presence of Kawasaki disease.Sci Rep. 2025 Mar 5;15(1):7693. doi: 10.1038/s41598-025-91935-8. Sci Rep. 2025. PMID: 40044787 Free PMC article.
-
Discrimination between incomplete and atypical Kawasaki syndrome versus other febrile diseases in childhood: results from an international registry-based study.Clin Exp Rheumatol. 2012 Sep-Oct;30(5):799-804. Epub 2012 Oct 17. Clin Exp Rheumatol. 2012. PMID: 23020938
-
Verification of Current Risk Scores for Kawasaki Disease in Korean Children.J Korean Med Sci. 2017 Dec;32(12):1991-1996. doi: 10.3346/jkms.2017.32.12.1991. J Korean Med Sci. 2017. PMID: 29115081 Free PMC article.
-
Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.Pediatr Res. 2015 Nov;78(5):547-53. doi: 10.1038/pr.2015.137. Epub 2015 Aug 3. Pediatr Res. 2015. PMID: 26237629 Free PMC article.
Cited by
-
A machine learning model for distinguishing Kawasaki disease from sepsis.Sci Rep. 2023 Aug 2;13(1):12553. doi: 10.1038/s41598-023-39745-8. Sci Rep. 2023. PMID: 37532772 Free PMC article.
-
Accuracy of Machine Learning in Discriminating Kawasaki Disease and Other Febrile Illnesses: Systematic Review and Meta-Analysis.J Med Internet Res. 2024 Nov 18;26:e57641. doi: 10.2196/57641. J Med Internet Res. 2024. PMID: 39556821 Free PMC article.
-
Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan.Children (Basel). 2021 Jul 23;8(8):623. doi: 10.3390/children8080623. Children (Basel). 2021. PMID: 34438515 Free PMC article.
-
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.Nat Commun. 2022 May 16;13(1):2687. doi: 10.1038/s41467-022-30357-w. Nat Commun. 2022. PMID: 35577777 Free PMC article.
-
Use of Machine Learning to Differentiate Children With Kawasaki Disease From Other Febrile Children in a Pediatric Emergency Department.JAMA Netw Open. 2023 Apr 3;6(4):e237489. doi: 10.1001/jamanetworkopen.2023.7489. JAMA Netw Open. 2023. PMID: 37040115 Free PMC article.
References
-
- Excellence NIfHaC. Feverish Illness in Children: Assessment and Initial Management in Children Younger Than 5 Years (Clinical guideline CG160.). 2013. - PubMed
-
- Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54(3):271–6. Epub 1974/09/01. . - PubMed
-
- McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927–e99. Epub 2017/03/31. 10.1161/CIR.0000000000000484 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials